Onesource Specialty
Ticker > Company >

Onesource Specialty share price

Onesource Specialty Pharma Ltd.

NSE: ONESOURCE BSE: 544292 SECTOR: Pharmaceuticals & Drugs  2730   4   1

1731.85
-16.20 (-0.93%)
BSE: 28 Mar 04:01 PM

Price Summary

Today's High

₹ 1763

Today's Low

₹ 1680.1

52 Week High

₹ 1774.3

52 Week Low

₹ 1163.05

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 19818.6 Cr.

Enterprise Value

₹ 19818.6 Cr.

No. of Shares

11.44 Cr.

P/E

0

P/B

1731.85

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1

CASH

0

DEBT

0

Promoter Holding

37.77 %

EPS (TTM)

₹  0

Sales Growth

ROE

ROCE

Profit Growth

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

Profit Growth

ROE%

ROCE %

ROA%

Net NPA%

 NIM

Debt/Equity

Price to Cash Flow

∞

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Price to Book Value

Advances Growth %

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2024 37.77 9.58
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Promoter pledging has increased from 0% to 9.58% in 1 quarter.
  • Company has a poor ROCE of 0% over the past 3 years
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024
Net Sales 67.98 336.75
Total Expenditure 67.86 236.37
Operating Profit 0.12 100.38
Other Income 0.58 5.01
Interest 20.71 43.92
Depreciation 19.06 33.98
Exceptional Items -0.95 -100.52
Profit Before Tax -40.02 -73.02
Tax 0 0
Profit After Tax -40.02 -73.02
Adjusted EPS (Rs) -9.63 -6.38

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)
profit & Loss is not available for this company.Report us

Balance Sheet (All Figures are in Crores.)

Particulars
Balance sheet is not available for this company.Report us
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)
Cash Flow data is not available for this company.Report us

Corporate Actions

Investors Details

PARTICULARS Dec 2024%
promoters 37.77
aditya arun kumar 0.03
arco lab private limited 1.61
arun kumar pillai 0.85
hemalatha pillai 0.03
karuna business solutions... 6.89
padmakumar karunakaran pi... 0.08
pronomz ventures llp 7.31
rajitha gopalakrishnan 0.03
sajitha pillai 0.04
tenshi pharmaceuticals pr... 20.82
vineetha mohanakumar pill... 0.08
PARTICULARS Dec 2024%
investors 62.23
360 one special opportuni... 1.62
amansa holdings private l... 1.32
authum investment and inf... 1.91
investor education and pr... 0.06
medella holdings pte. ltd... 4.17
mukul mahavir agrawal 1.42
nova global opportunities... 1.57
quant mutual fund - quant... 2.17
route one fund i, l.p. 2.07
route one offshore master... 2.33
sbi life insurance compan... 1.48
think investments pcc 2.02
timf holdings 2.41

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

Company Presentations

Last Updated on:
Brief about Onesource Specialty
X